Hemoglobin level is positively associated with blood pressure in a large cohort of healthy individuals

Hypertension

Volumn 60, Issue 4, 2012, Pages 936-941

  Atsma, Femke ^a   Veldhuizen, Ingrid ^a   De Kort, Wim ^a   Van Kraaij, Marian ^b   Pasker De Jong, Pieternel ^a   Deinum, Jaap ^c  

^a SANQUIN RESEARCH   (Netherlands)

^b Sanquin Bloedbank Regio Zuidoost Nijmegen   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

blood pressure; diastole; epidemiology; hemoglobin; systole

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD PRESSURE MONITORING; BODY MASS; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; COHORT STUDIES; FEMALE; HEMOGLOBINS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NETHERLANDS;

EID: 84866559392     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.193565     Document Type: Article

References (29)

1. World Health Organization. Cardiovascular diseases (CVDs). http://www.who.int/mediacentre/factsheets/fs317/en/. Accessed February 7, 2012.
2. Lawes CM, Vander HS, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513-1518.
3. Geleijnse JM. Zout, bloeddruk en hart-en vaatziekten. In: Vaartjes I, van Dis I, Visseren FLJ, Bots ML. Hart-en Vaatziekten in Nederland 2011, Cijfers Over Leefstijl-en Risicofactoren, Ziekte en Sterfte. The Netherlands: The Hague. 2011;73-90.
4. Staessen JA, Birkenhager WH. Evidence that new antihypertensives are superior to older drugs. Lancet. 2005;366:869-871.
5. Göbel BO, Schulte-Gobel A, Weisser B, Glanzer K, Vetter H, Dusing R. Arterial blood pressure: correlation with erythrocyte count, hematocrit, and hemoglobin concentration. Am J Hypertens. 1991;4:14-19.
6. Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Katoh T, Ohtsuka N, Takayama S, Abe M. A slightly low hemoglobin level is benefcially associated with arterial stiffness in Japanese community-dwelling women. Clin Exp Hypertens. 2012;34:92-98.
7. Chambers JK. Case study of the anemic patient: epoetinalfa-focus on blood pressure. ANNA J. 1994;21:154-157.
8. Kanbay M, Akcay A, Delibasi T, Uz B, Kaya A, Koca C, Turgut F, Bavbek N, Uz E, Duranay M, Yigitoglu R. Comparison of effects of darbepoeti-nalfa and epoetinalfa on serum endothelin level and blood pressure. Adv Ther. 2007;24:346-352.
9. Hoeldtke RD, Streeten DH. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med. 1993;329:611-615.
10. Ferrera R, Hadour G, Chiari P, Montagna P, Jegaden O, Burhop K, Lehot JJ. Effect of diaspirin cross-linked haemoglobin (DCLHb) on mean arterial pressure during cardiopulmonary bypass in swine. Transfus Med. 2002;12:311-316.
11. Cabrales P, Han G, Nacharaju P, Friedman AJ, Friedman JM. Reversal of hemoglobin-induced vasoconstriction with sustained release of nitric oxide. Am J Physiol Heart Circ Physiol. 2011;300:H49-H56.
12. Cabrales P, Sun G, Zhou Y, Harris DR, Tsai AG, Intaglietta M, Palmer AF. Effects of the molecular mass of tense-state polymerized bovine hemoglobin on blood pressure and vasoconstriction. J Appl Physiol. 2009;107:1548-1558.
13. Atsma F, Veldhuizen IJT, de Vegt F, Doggen CJM, de Kort WLAM. Cardiovascular and demographic characteristics of whole blood and plasma donors: results from the Donor InSight Study. Transfusion. 2011;51:412-420.
14. Atsma F, Veldhuizen IJT, Verbeek A, de Kort WLAM, de Vegt F. Healthy donor effect: its magnitude in health research among blood donors. Transfusion. 2011;51:1820-1828.
15. Commssion Directive 2004/33/EC. Implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components. Offcial Journal of the European Union. 2004;Annex III:31-34.
16. Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59:1087-1091.
17. Hoekstra T, Veldhuizen IJT, van Noord PA, de Kort WLAM. Seasonal infuences on hemoglobin levels and deferral rates in whole-blood and plasma donors. Transfusion. 2007;47:895-900.
18. Kristal-Boneh E, Harari G, Green MS, Ribak J. Summer-winter variation in 24 h ambulatory blood pressure. Blood Press Monit. 1996;1:87-94.
19. Alperovitch A, Lacombe JM, Hanon O, Dartigues JF, Ritchie K, Ducimetiere P, Tzourio C. Relationship between blood pressure and outdoor temperature in a large sample of elderly individuals: the Three-City Study. Arch Intern Med. 2009;169:75-80.
20. The Royal Netherlands Meteorological Institute. KNMI Data Centre. http://www.knmi.nl/datacentre/. Accessed February 1, 2011.
21. Piperno A, Trombini P, Gelosa M, Mauri V, Pecci V, Vergani A, Salvioni A, Mariani R, Mancia G. Increased serum ferritin is common in men with essential hypertension. J Hypertens. 2002;20:1513-1518.
22. Lowe GD, Lee AJ, Rumley A, Price JF, Fowkes FG. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol. 1997;96:168-173.
23. Devereux RB, Case DB, Alderman MH, Pickering TG, Chien S, Laragh JH. Possible role of increased blood viscosity in the hemodynamics of systemic hypertension. Am J Cardiol. 2000;85:1265-1268.
24. Salazar Vazquez BY. Blood pressure and blood viscosity are not correlated in normal healthy subjects. Vasc Health Risk Manag. 2012;8:1-6.
25. Martini J, Carpentier B, Negrete AC, Frangos JA, Intaglietta M. Paradoxical hypotension following increased hematocrit and blood viscosity. Am J Physiol Heart Circ Physiol. 2005;289:H2136-H2143.
26. Bertinieri G, Parati G, Ulian L, Santucciu C, Massaro P, Cosentini R, Torgano G, Morganti A, Mancia G. Hemodilution reduces clinic and ambulatory blood pressure in polycythemic patients. Hypertension. 1998;31:848-853.
27. Klaassen RJ, van GT, Rischen-Vos J, Deinum J, Man in't Veld AJ, Weimar W. Losartan, an angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplanterythrocy-tosis. Transplantation. 1997;64:780-782.
28. Freudenthaler SM, Schenck T, Lucht I, Gleiter CH. Fenoterol stimulates human erythropoietin production via activation of the renin angiotensin system. Br J ClinPharmacol. 1999;48:631-634.
29. Biaggioni I, Robertson D, Krantz S, Jones M, Haile V. The anemia of primary autonomic failure and its reversal with recombinant erythropoi-etin. Ann Intern Med. 1994;121:181-186.